Chemoinformaics analysis of Octadecanoic acid, 2,3-dihydroxypropyl ester
| Molecular Weight | 358.563 | nRot | 19 |
| Heavy Atom Molecular Weight | 316.227 | nRig | 1 |
| Exact Molecular Weight | 358.308 | nRing | 0 |
| Solubility: LogS | -4.526 | nHRing | 0 |
| Solubility: LogP | 6.765 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 67 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 66.2833 |
| nHD | 2 | BPOL | 44.7387 |
| QED | 0.248 |
| Synth | 2.536 |
| Natural Product Likeliness | 0.65 |
| NR-PPAR-gamma | 0.732 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.01 |
| Pgp-sub | 0.9 |
| HIA | 0.011 |
| CACO-2 | -4.867 |
| MDCK | 0.0000278 |
| BBB | 0.049 |
| PPB | 0.973939 |
| VDSS | 0.729 |
| FU | 0.0147039 |
| CYP1A2-inh | 0.341 |
| CYP1A2-sub | 0.162 |
| CYP2c19-inh | 0.275 |
| CYP2c19-sub | 0.053 |
| CYP2c9-inh | 0.205 |
| CYP2c9-sub | 0.913 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.047 |
| CYP3a4-inh | 0.39 |
| CYP3a4-sub | 0.052 |
| CL | 7.36 |
| T12 | 0.527 |
| hERG | 0.254 |
| Ames | 0.018 |
| ROA | 0.017 |
| SkinSen | 0.941 |
| Carcinogencity | 0.067 |
| EI | 0.146 |
| Respiratory | 0.452 |
| NR-Aromatase | 0.302 |
| Antiviral | Yes |
| Prediction | 0.787489 |